Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,154
archived clinical trials in
Osteoarthritis (OA)

Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Taylor Research LLC
mi
from
Marietta, GA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Taylor Research LLC
mi
from
Marietta, GA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Drug Studies America
mi
from
Marietta, GA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Drug Studies America
mi
from
Marietta, GA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
In-Quest Medical Research, LLC
mi
from
Norcross, GA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
In-Quest Medical Research, LLC
mi
from
Norcross, GA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Global Scientific Innovations
mi
from
Evansville, IN
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Global Scientific Innovations
mi
from
Evansville, IN
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Integrated Clinical Trials Services, Inc.
mi
from
West Des Moines, IA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Integrated Clinical Trials Services, Inc.
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Clinical Trials Management
mi
from
Metairie, LA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Clinical Trials Management
mi
from
Metairie, LA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Best Clinical Trials, LLC
mi
from
New Orleans, LA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Best Clinical Trials, LLC
mi
from
New Orleans, LA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
River Cities Clinical Research Center
mi
from
Shreveport, LA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
River Cities Clinical Research Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
New England Center for Clinical Research
mi
from
Fall River, MA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
New England Center for Clinical Research
mi
from
Fall River, MA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Great Lakes Research Group
mi
from
Bay City, MI
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Great Lakes Research Group
mi
from
Bay City, MI
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Cadillac Clinical Research
mi
from
Cadillac, MI
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Cadillac Clinical Research
mi
from
Cadillac, MI
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
The Center For Clinical Trials
mi
from
Biloxi, MS
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
The Center For Clinical Trials
mi
from
Biloxi, MS
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Long Island Gastrointestinal Research Group
mi
from
Great Neck, NY
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Long Island Gastrointestinal Research Group
mi
from
Great Neck, NY
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Upstate Clinical Research Associates
mi
from
Williamsville, NY
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Upstate Clinical Research Associates
mi
from
Williamsville, NY
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Plains Medical Clinic
mi
from
Fargo, ND
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Plains Medical Clinic
mi
from
Fargo, ND
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Clinical Inquest Center Ltd.
mi
from
Beavercreek, OH
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Clinical Inquest Center Ltd.
mi
from
Beavercreek, OH
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
New Horizons Clinical Research
mi
from
Cincinnati, OH
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
New Horizons Clinical Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Prestige Clinical Research
mi
from
Franklin, OH
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Prestige Clinical Research
mi
from
Franklin, OH
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Optimed Research, Ltd.
mi
from
Tiffin, OH
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Optimed Research, Ltd.
mi
from
Tiffin, OH
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Brandywine Clinical Research
mi
from
Downingtown, PA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Brandywine Clinical Research
mi
from
Downingtown, PA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Pain Specialists of Charleston, P.A.
mi
from
Charleston, SC
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Pain Specialists of Charleston, P.A.
mi
from
Charleston, SC
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Health Concepts
mi
from
Rapid City, SD
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Health Concepts
mi
from
Rapid City, SD
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
FutureSearch Clinical Trials
mi
from
Austin, TX
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
FutureSearch Clinical Trials
mi
from
Austin, TX
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
KRK Medical Research
mi
from
Dallas, TX
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
KRK Medical Research
mi
from
Dallas, TX
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research of Houston
mi
from
Houston, TX
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Trials
mi
from
San Antonio, TX
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Trials
mi
from
San Antonio, TX
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Highland Clinical Research
mi
from
Salt Lake City, UT
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Highland Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Clinical Investigations Specialist, Inc.
mi
from
Kenosha, WI
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Clinical Investigations Specialist, Inc.
mi
from
Kenosha, WI
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Florida Health Center
mi
from
Fort Lauderdale, FL
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Florida Health Center
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Ribo Research, LLC dba Peninsula Research, Inc.
mi
from
Ormond Beach, FL
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Ribo Research, LLC dba Peninsula Research, Inc.
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
Willis-Knighton Physician Network
mi
from
Bossier City, LA
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
Willis-Knighton Physician Network
mi
from
Bossier City, LA
Click here to add this to my saved trials
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated:  12/31/1969
The Center for Clinical Research
mi
from
Winston-Salem, NC
Long-term Open-Label Safety Study to Evaluate EN3409
A Phase 3, Open-label, Long-term Study to Evaluate the Safety, Tolerability, and Analgesic Efficacy of BEMA® Buprenorphine in Subjects With Moderate to Severe Chronic Pain Requiring Continuous Around-the-Clock Opioid Analgesia for an Extended Period of Time
Status: Enrolling
Updated: 12/31/1969
The Center for Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Ellis and Badenhausen Orthopedics PSC
mi
from
Louisville, KY
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Ellis and Badenhausen Orthopedics PSC
mi
from
Louisville, KY
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Peninsula Orthopaedics Associates, P.A.
mi
from
Salisbury, MD
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Peninsula Orthopaedics Associates, P.A.
mi
from
Salisbury, MD
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Essentia Health Duluth
mi
from
Duluth, MN
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Essentia Health Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
SUNY Upstate Medical Universtiy
mi
from
East Syracuse, NY
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
SUNY Upstate Medical Universtiy
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
OhioHealth Research Institute at Grant Medical Center
mi
from
Columbus, OH
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
OhioHealth Research Institute at Grant Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Western Orthopaedics
mi
from
Denver, CO
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Western Orthopaedics
mi
from
Denver, CO
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
University Orthopedics
mi
from
Altoona, PA
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
University Orthopedics
mi
from
Altoona, PA
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Rothman Institute
mi
from
Philadelphia, PA
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Rothman Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Southern Oregon Orthopedics
mi
from
Medford, OR
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Southern Oregon Orthopedics
mi
from
Medford, OR
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Banner Research
mi
from
Sun City, AZ
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Banner Research
mi
from
Sun City, AZ
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Orthopedics Stanford University
mi
from
Redwood City, CA
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Orthopedics Stanford University
mi
from
Redwood City, CA
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Midwest Orthopaedics at Rush
mi
from
Chicago, IL
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Midwest Orthopaedics at Rush
mi
from
Chicago, IL
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Medstar Health Research Institute
mi
from
Hyattsville, MD
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Medstar Health Research Institute
mi
from
Hyattsville, MD
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Excelsior Orthopedics
mi
from
Amherst, NY
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Excelsior Orthopedics
mi
from
Amherst, NY
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Adena Health System
mi
from
ChillIcothe, OH
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Adena Health System
mi
from
ChillIcothe, OH
Click here to add this to my saved trials
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated:  12/31/1969
Palmetto Health Orthopedics (formerly Providence Orthopedics Group, LLC_Moore Orthopedics)
mi
from
Columbia, SC
Arthrex Eclipse™ Shoulder Prosthesis
A Prospective, Randomized, Multicenter Study Comparing the Safety and Effectiveness of Arthrex's Eclipse™ Shoulder Prothesis to the Univers™ II Shoulder Prosthesis in Patients With a Degenerative Joint Disease
Status: Enrolling
Updated: 12/31/1969
Palmetto Health Orthopedics (formerly Providence Orthopedics Group, LLC_Moore Orthopedics)
mi
from
Columbia, SC
Click here to add this to my saved trials